Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

3.40
Delayed Data
As of Apr 24
 +0.03 / +0.89%
Today’s Change
2.88
Today|||52-Week Range
5.18
-13.27%
Year-to-Date
No recent news for Brainstorm Cell Therapuetics Inc.

Today’s Trading

Previous close3.37
Today’s open3.41
Day’s range3.30 - 3.42
Volume28,601
Average volume (3 months)76,557
Market cap$65.0M
Data as of 4:00pm ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)+3.70%
Earnings growth (this year)-353.85%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book11.00

Competitors

 Today’s
change
Today’s
% change
IMMPImmutep Ltd0.000.00%
AEZSAEterna Zentaris Inc-0.06-3.73%
PRTOProteon Therapeutics...-0.10-4.35%
HTGMHTG Molecular Diagno...+0.08+2.36%
Data as of 4:00pm ET, 04/24/2018

Financials

Next reporting dateMay 17, 2018
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$0.00
Annual profit (last year)-$5.0M
Net profit margin--

Profile

Sector
Electronic Technology
Industry
Computer Peripherals
President &
Chief Executive Officer
Chaim Lebovits
Chief Operating &
Medical Officer
Ralph Z. Kern
Corporate headquarters
Hackensack, New Jersey

Forecasts